Hedgehog signaling in prostate growth and benign prostate hyperplasia

被引:19
|
作者
Vezina C.M. [1 ]
Bushman W. [1 ]
机构
[1] Department of Surgery, University of Wisconsin-Madison, Clinical Science Center-G5, Madison, WI 53792
关键词
Benign Prostate Hyperplasia; Hedgehog Signaling; Cyclopamine; Indian Hedgehog; Prostate Development;
D O I
10.1007/s11934-007-0073-x
中图分类号
学科分类号
摘要
Hedgehog (Hh) signaling has long been recognized for its role in axial patterning, mesenchymal-epithelial inductive signaling, and growth regulation during fetal development. In many embryonic tissues, Hh functions as a proliferative stimulus. Sonic hedgehog and Indian hedgehog are both expressed by the urothelium of the fetal prostate anlage, where they regulate cell proliferation and differentiation and play a role in prostate ductal budding. Whereas Hh signaling in mouse prostate diminishes during adolescence and is maintained at a bw level in the adult, robust Hh signaling is commonly found in the adult human prostate. The reason(s) for robust Hh signaling in the adult human prostate and the actions of Hh signaling on growth and differentiation in the adult are not well understood. However, increased Hh signaling has been associated with prostate cancer and has been shown to accelerate prostate cancer growth. These observations suggest that inappropriate reawakening of this developmental growth signal may play a pivotal role in prostate neoplasia. This review examines the role of Hh signaling during early prostate growth and in its corollary actions during prostate disease, including benign prostate hyperplasia and prostate cancer. The use of Hh inhibitors as a therapeutic modality for androgen-independent treatment of prostate disease is also discussed. Copyright © 2007 by Current Medicine Group LLC.
引用
下载
收藏
页码:275 / 280
页数:5
相关论文
共 50 条
  • [41] Laser Therapy for Benign Prostate Hyperplasia
    Muschter, R.
    AKTUELLE UROLOGIE, 2008, 39 (05) : 359 - 368
  • [42] Oxidative stress in benign prostate hyperplasia
    Zabaiou, N.
    Mabed, D.
    Lobaccaro, J. M.
    Lahouel, M.
    ANDROLOGIA, 2016, 48 (01) : 69 - 73
  • [43] Benign prostatic hyperplasia, prostate cancer
    Lebdai, S.
    PROGRES EN UROLOGIE, 2017, 27 (03): : F60 - F62
  • [44] Laser Applications for Benign Prostate Hyperplasia
    Akyuz, Osman
    KONURALP TIP DERGISI, 2012, 4 (01): : 50 - 53
  • [45] Natural history of benign prostate hyperplasia
    WU ShiliangLI NingchenXIAO YunxiangJIN JieQIU ShaopengYE ZhangqunKONG ChuizeSUN Guang and NA Yanqun Department of UrologyPeking University First HospitalBeijing China Department of UrologyFirst Affiliate Hospital of Zhongshan Medical UniversityGuangzhou China Department of UrologyTongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan China Department of UrologyFirst Clinical HospitalChina Medical UniversityShenyang China Institute of UrologyTianjin Medical UniversityTianjin China
    ChineseMedicalJournal, 2006, (24) : 2085 - 2089
  • [46] Benign prostatic hyperplasia (the aging prostate)
    Medina, JJ
    Parra, RO
    Moore, RG
    MEDICAL CLINICS OF NORTH AMERICA, 1999, 83 (05) : 1213 - +
  • [47] Alfuzosin for the management of benign prostate hyperplasia
    Weiner, DM
    Lowe, FC
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (11) : 2057 - 2063
  • [48] Benign prostatic hyperplasia, prostate cancer
    Mathieu, R.
    PROGRES EN UROLOGIE, 2015, 25 (02): : F58 - F60
  • [49] Natural history of benign prostate hyperplasia
    Wu Shi-liang
    Li Ning-chen
    Xiao Yun-xiang
    Jin Jie
    Qiu Shao-peng
    Ye Zhang-qun
    Kong Chui-ze
    Sun Guang
    Na Yan-qun
    CHINESE MEDICAL JOURNAL, 2006, 119 (24) : 2085 - 2089
  • [50] Etiology and pathophysiology of benign prostate hyperplasia
    Roosen, A.
    Gratzke, C.
    Herlemann, A.
    Magistro, G.
    Strittmatter, F.
    Weinhold, P.
    Tritschler, S.
    Stief, C. G.
    UROLOGE, 2013, 52 (02): : 186 - +